ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+9.43%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$168M
AUM Growth
+$168M
(-6.7%)
Cap. Flow
-$16.8M
Cap. Flow
% of AUM
-10.02%
Top 10 Holdings %
Top 10 Hldgs %
55.87%
Holding
32
New
10
Increased
1
Reduced
13
Closed
7
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$11.6M |
| 2 |
Legend Biotech
LEGN
|
$8.64M |
| 3 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$8.23M |
| 4 |
Disc Medicine
IRON
|
$7.5M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
$7.39M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$11.9M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$9.19M |
| 3 |
Insmed
INSM
|
$8.11M |
| 4 |
Dianthus Therapeutics
DNTH
|
$6.51M |
| 5 |
Olema Pharmaceuticals
OLMA
|
$6.33M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
26
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-394,773
| Closed | -$3.57M |
|
|
VRNA
27
Verona Pharma
VRNA
$9.18B
| – | – |
-736,738
| Closed | -$11.9M |
|
28
RAPT Therapeutics
RAPT
$187M
| – | – |
-420,000
| Closed | -$3.77M |
|
|
29
Olema Pharmaceuticals
OLMA
$432M
| – | – |
-559,035
| Closed | -$6.33M |
|
30
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-801,437
| Closed | -$3.59M |
|
31
Lyra Therapeutics
LYRA
$11.8M
| – | – |
-1,003,741
| Closed | -$6.24M |
|
|
32
Dianthus Therapeutics
DNTH
$781M
| – | – |
-216,968
| Closed | -$6.51M |
|